Elanco Animal Health shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $13 to $20.
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health's stock (ELAN) is trading higher following an upgrade from Stifel, moving from a Hold to a Buy rating, with an increased price target from $13 to $20.

January 05, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel upgraded Elanco Animal Health (ELAN) from Hold to Buy and raised the price target from $13 to $20, indicating a positive outlook on the stock.
Analyst upgrades typically lead to a positive short-term reaction in the stock market as they suggest a better-than-previously-expected performance and outlook for the company. The substantial increase in the price target from $13 to $20 by Stifel reflects a strong conviction in Elanco's potential, likely resulting in increased investor confidence and upward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100